Assessing Novel Methods of Improving Patient Education of Nutrition
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00394576|
Recruitment Status : Unknown
Verified February 2009 by University of Wisconsin, Madison.
Recruitment status was: Recruiting
First Posted : November 1, 2006
Last Update Posted : February 16, 2009
|First Submitted Date ICMJE||October 30, 2006|
|First Posted Date ICMJE||November 1, 2006|
|Last Update Posted Date||February 16, 2009|
|Start Date ICMJE||November 2006|
|Estimated Primary Completion Date||June 2009 (Final data collection date for primary outcome measure)|
|Current Primary Outcome Measures ICMJE
|Original Primary Outcome Measures ICMJE
|Change History||Complete list of historical versions of study NCT00394576 on ClinicalTrials.gov Archive Site|
|Current Secondary Outcome Measures ICMJE
||After all groups have completed their visits, correlations between dietary phosporus intake, serum phosphorous levels and CECs will be made. [ Time Frame: two years for all subjects to be enrolled, data to be analyzed ]|
|Original Secondary Outcome Measures ICMJE
||After all groups have completed their visits, correlations between dietary phosporus intake, serum phosphorus levels and CECs will be made.|
|Current Other Outcome Measures ICMJE||Not Provided|
|Original Other Outcome Measures ICMJE||Not Provided|
|Brief Title ICMJE||Assessing Novel Methods of Improving Patient Education of Nutrition|
|Official Title ICMJE||Assessing Novel Methods of Improving Patient Education of Nutrition: eHealth, Health Literacy and Chronic Kidney Disease|
The relationship between elevated phosphorus levels and morbidity and mortality in patients with chronic kidney disease (CKD) is well recognized, and dietary phosphorus restriction is a mainstay of phosphate management. Despite this, appropriate control of phosphate intake remains sub-par, due in part to the difficulties that patients have understanding phosphate content in foods. Randomized trials have shown that intensive, individualized dietary counseling can improve patient knowledge about phosphorus and help control hyperphosphatemia; however, maintaining this level of counseling is time-consuming, costly, and impractical. Given the recognized nephrology workforce shortage, there is a crucial need for systems to fill this gap with novel technologies to educate patients, and it is vital that a better understanding of the effects of novel nutritional intervention counseling methods on patient knowledge, nutritional intake and nutritional status be evaluated in CKD patients.
Furthermore, to effectively engage in the patient side of the education process, those who receive it, the patients, must be able to comprehend information and draw on it for decision-making. Novel educational interventions may be better suited than traditional methods to circumvent literacy limitations. Therefore, it is vital to assess the relation of functional health literacy of this population in both traditional and emerging educational venues.
Finally, the importance of phosphorus control for patients with CKD has traditionally been to prevent bone disease. More recently it is recognized that poor phosphorus control correlates with cardiovascular disease, of which patients with CKD carry an enormous burden. Similarly, there has recently been much attention to circulating endothelial cells (CECs) as a novel marker for cardiovascular risk in this population. While the ultimate test would be to determine if controlling phosphorus impacts on cardiovascular events, that is beyond the scope of this project. Therefore, we propose to measure levels of CECs as an intermediary step toward cardiovascular events, in correlation to phosphorus intake.
Hypothesis 1: Novel nutritional educational interventions of dietary phosphorus can be useful for providing improvements on phosphorus knowledge and control of intake. Significance: Such methods can be self-sustaining, and therefore a practical solution to the problem of providing continuous and repeated educational interventions given limited provider time and resources.
Hypothesis 2: A higher level of health literacy in individuals with CKD is associated with greater knowledge of and compliance with recommended dietary phosphorus intake. Significance: A better understanding of obstacles to optimal nutritional intake will lead to improved methods for nutrition intervention counseling. Alternative measures to educate those with lower health literacy may require a shifting of resources for this subgroup of individuals.
Hypothesis 3: Higher dietary phosphorus intake in individuals with CKD correlates with higher levels of CECs.
Specific Aim 1: To examine the effect of a novel, web-based method of educating CKD patients on patient knowledge and dietary intake of phosphorus. We will compare 2 methods for educating CKD patients about dietary phosphorus intake:
Specific Aim 2: To determine if the S-TOFHLA predicts CKD patients' knowledge and compliance with recommended dietary phosphorus intake:
Specific Aim 3: To determine if higher dietary phosphorus intake correlates with higher levels of CECs.
Following enrollment and informed consent, subjects will be randomized to one of two arms (group1: usual care; group 2: usual care plus KS module). All subjects will undergo baseline data collection, as shown in table 1. KS and Survey information is as follows:
Kidney School (KS). KS (http://www.kidneyschool.org) is an online, personalized, interactive self-management learning center created by the Madison, WI based Medical Education Institute (MEI) and organized into fifteen 20-30 minute modules, each focused on a different topic related to kidney disease and its treatment, including nutrition. Content is based on 10 years of research conducted by the Life Options Rehabilitation Program, with internal and external expert review. The nutrition module is tailored for patients with or without diabetes.
Proprietary Information. The mission of the non-profit MEI is to help people with chronic diseases learn to manage and improve their health, through research and education. The MEI believes charging a fee for educational materials can be a barrier between patients and the information they need to live successfully with a chronic disease. All MEI-developed patient education materials are therefore free. KS is entirely proprietary to the MEI, but will continue to be available free of charge via the Internet.
HIPAA. KS is fully compliant with HIPAA standards. S-TOFHLA. An abbreviated version of the test of functional health literacy in adults, the S-TOFHLA is widely used by health care providers to determine the adequacy of their patients' understanding of health care materials needed for their health care or education, as well as by researchers to assess health literacy as a variable in research. It categorizes individuals as having adequate, marginal or inadequate health literacy, can be administered in 12 minutes, and has been used in patients with a variety of chronic diseases.
CKD Knowledge Assessment Tool (CKDKAT) of Nutrition. The CKDKAT of nutrition is a revised version of our original CKDKAT, which addresses only nutritional knowledge specific to CKD. Fifteen of 25 questions are phosphorus-specific, with the remaining 10 concerning sodium, potassium and protein intake.
SF-12v2. The SF-12 Health Survey version 2 is a 12-item measure of health related quality of life. Widely used in research in a variety of disease states, including CKD, it provides physical and mental component summary scores with a strong concordance with the lengthier SF-36. Given that we will be administering multiple cognitive and behavioral surveys to subjects, the shorter version will be used.
Kidney Disease Self-Management Survey (KDSMS). Developed by MEI, the KDSMS is a 58-item Likert scale with 6 subscales, based on theories deemed important for self-management education in other chronic diseases, including the health belief model, self-efficacy, behavioral intent, and the transtheoretical model. These theories converge into a self-management education schema that emphasizes the importance of information, support, modeling, planning, practice and monitoring, and reflection in patient self-management education. The 6 subscales are: 1) Self-monitoring, 2) Adjusting to symptoms, 3) Lifestyle behaviors, 4) Medication-taking, 5) Information seeking, 6) Doctor/patient communication.
24 hour recall diaries. After collecting the information from subjects, nutrient analysis will be performed using The Food Processor SQL Nutrition Software (ESHA Research, Salem, Oregon).
The study instruments will all performed for research purposes. While some of them (the S-TOFHLA, 3-Day Dietary Diaries) have been used as part of patient care, this is not routine, and it is not done at our facilities.
Lab work collected will consist of serum phosphorus, calcium and intact-parathyroid hormone levels. As these are routinely collected prior to or during a regular CKD clinic visit, the study coordinator will check to see if this data is already available, and will not duplicate this blood work if it is. In addition, all subjects will have blood drawn (30 ml) for assessment of circulating endothelial cells (CECs), a novel marker for vascular damage.
Following baseline data collection, group 1 will continue with their scheduled clinic visit, while group 2 will spend approximately 30 minutes completing the KS nutrition module at a dedicated computer education station at the UW Kidney Clinic. The study coordinator will bring up the KS nutrition module (tailored for diabetes as a co-morbidity if appropriate). After completion of the KS nutrition module, patients will receive a personalize action plan, and then proceed with their scheduled clinic visit.
All subjects will then be asked to return in 30-60 days to repeat some of the survey information and blood work.
All subjects (N = 100) will be recruited from the UW Health Kidney Clinic. We will recruit individuals in the later stages of kidney disease: Stages 3 and 4. Staging of CKD is determined by estimating the glomerular filtration rate (e-GFR). The e-GFR is automatically calculated with each outpatient serum creatinine ordered through the UW labs, and so this information is readily available. Stage 3 is defined as GFR of 30-59 milliliters/minute (~ ½ to ¼ of normal kidney function), and Stage 4 is defined as a GFR of 15-29 milliliters/minute (~ ¼ to ⅛ of normal kidney function). Stage 5 is kidney failure (GFR < 15 milliliters/minute).
All patients between the ages of 18 and 89 with CKD stage 3 or 4 who are seen in the UW Health Kidney Clinic will be invited to participate in the study by a member of the study personnel prior to beginning the class or while waiting for their clinic visit. Fliers briefly describing the study with contact information for those interested will be available at the receptionist area in the UW Kidney Clinic and in the computer-station education area. Demographic information collected will include age, gender, race, length of time with known CKD, education level, and home computer ownership.
Subjects will receive modest compensation for their time and effort ($10 after completion of first set of data collection, $25 after completion of follow up data collection). No project personnel will receive incentives for recruiting human subjects or for any other purpose directly related to the study. The greater amount offered for the second visit is due to the added inconvenience of returning for an additional visit.
Note, as prisoners are not seen in the UW Kidney Clinic, the study will not involve this population.
Statistical Justification of Sample Size
We propose a sample size of 50 subjects for each of the cohorts. Pairwise comparisons of mean knowledge scores of Cohort 2 with Cohort 1 (i.e., the original cohort taking the test prior to any educational intervention) will be conducted using two-sided t-tests to detect a p-value of < 0.05. Adjustments will be made for demographic factors known to be related to chronic disease knowledge, including age, race, gender and education. The effective sample size will provide 80% power to detect a difference in mean knowledge scores of 3 or more questions.
Correlation between higher levels of functional health literacy and increased knowledge of kidney disease will be determined using Spearman rank-order correlation.
Risks and Benefits to Participants
It is not anticipated that there are any significant or sustained risks to subjects of participation in the study. There is the potential for some mild discomfort from the necessary blood draws, which occur twice per subjects.
Personal benefits to subjects: Subjects randomized to the KS nutrition module may receive benefit from the personalized action plan, and may gain knowledge of nutritional needs for their chronic condition.
Scientific benefits from the study: A better understanding of obstacles to optimal nutritional intake will lead to improved methods for nutrition intervention counseling. Alternative measures to educate those with lower health literacy may require a shifting of resources for this subgroup of individuals.
As the study requires the ability to fill out multiple surveys and use the Internet, only individuals who can provide their own consent can participate. The consent process will be conducted by either the Study Coordinator (Lynn Jacobson) or the PI (Jonathan Jaffery). Upon agreeing to enroll in the study, the subject with a copy of the consent form (see attached). The individual obtaining consent will remain available to answer any and all questions.
Changes to the protocol were submitted and approved:
The changes are being made because additional funding has been awarded to look further at the same question in a slightly different patient population. The previously approved study enrolls individuals with chronic kidney disease (CKD) stages 3 and 4 (moderate to severe CKD). The proposed changes will include individuals with CKD 5 (end-stage kidney disease) undergoing maintenance hemodialysis (MD). Given the major differences in how these groups of patients receive care (clinic visits averaging every 3-6 months with occasional blood work and primarily oral medications arranged per provider discretion for those with CKD 3 and 4, versus dialysis unit treatments of 3-4 hours/3 times weekly, with monthly blood work and various oral and IV medications prescribed per protocols for those with CKD 5 on MD), it is important to assess the proposed questions in both distinct groups.
Subjects with CKD 5 will have a decreased risk of adverse effects, due to the lack of any need for blood draws. Additionally, the time spent performing study questionnaires or engaging with the web-based module (via wireless-enabled laptop) will be during the 3-4 hour dialysis treatment, and so will not prolong their visit length. Subjects with CKD 3 and 4 will not be affected by the changes.
|Study Type ICMJE||Interventional|
|Study Phase||Not Provided|
|Study Design ICMJE||Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
|Condition ICMJE||Chronic Kidney Disease|
|Publications *||Not Provided|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Recruitment Status ICMJE||Unknown status|
|Estimated Enrollment ICMJE||180|
|Estimated Completion Date||June 2009|
|Estimated Primary Completion Date||June 2009 (Final data collection date for primary outcome measure)|
|Eligibility Criteria ICMJE||
|Ages||18 Years to 90 Years (Adult, Senior)|
|Accepts Healthy Volunteers||No|
|Contacts ICMJE||Contact information is only displayed when the study is recruiting subjects|
|Listed Location Countries ICMJE||United States|
|Removed Location Countries|
|NCT Number ICMJE||NCT00394576|
|Other Study ID Numbers ICMJE||H-2006-0186-1
5 K12 RRO17614A
|Has Data Monitoring Committee||No|
|U.S. FDA-regulated Product||Not Provided|
|IPD Sharing Statement||Not Provided|
|Responsible Party||Jonathan B. Jaffery, MD, University of Wisconsin|
|Study Sponsor ICMJE||University of Wisconsin, Madison|
|Collaborators ICMJE||Not Provided|
|PRS Account||University of Wisconsin, Madison|
|Verification Date||February 2009|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP